Bickerstaff brainstem encephalitis
| Bickerstaff brainstem encephalitis | |
|---|---|
| Synonyms | Bickerstaff's encephalitis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Ophthalmoplegia, ataxia, hyperreflexia, altered consciousness |
| Complications | Respiratory failure, coma |
| Onset | Acute |
| Duration | Variable |
| Types | N/A |
| Causes | Often associated with autoimmune response, sometimes following infection |
| Risks | History of infection, autoimmune disorders |
| Diagnosis | Clinical diagnosis, supported by MRI, CSF analysis, and nerve conduction studies |
| Differential diagnosis | Guillain–Barré syndrome, Miller Fisher syndrome, brainstem stroke |
| Prevention | N/A |
| Treatment | Intravenous immunoglobulin, plasmapheresis, corticosteroids |
| Medication | N/A |
| Prognosis | Generally good with treatment, but can vary |
| Frequency | Rare |
| Deaths | N/A |
Bickerstaff Brainstem Encephalitis (BBE) is a rare inflammatory disorder of the central nervous system, primarily affecting the brainstem and occasionally extending to the cerebellum and cerebrum. It is characterized by acute onset of diplopia (double vision), ataxia (lack of muscle coordination), and areflexia (absence of neurologic reflexes), closely resembling Guillain-Barré syndrome (GBS), with which it shares several immunological features. The condition is named after Edwin Bickerstaff, a British neurologist who first described the syndrome in 1951.
Symptoms and Signs
BBE presents with a distinctive clinical triad:
- Diplopia: This results from paresis of one or more of the six cranial nerves that control eye movement.
- Ataxia: Patients may experience unsteadiness and coordination problems due to involvement of the brainstem and cerebellum.
- Areflexia: The absence or decrease of reflexes is a common feature, similar to that observed in Guillain-Barré syndrome.
Additional symptoms may include altered consciousness, ranging from drowsiness to coma, and long-tract signs such as spasticity and hyperreflexia. Facial weakness, bulbar palsy, and sensory disturbances may also occur.
Etiology
The exact cause of BBE is not fully understood, but it is believed to be an autoimmune disorder triggered by a preceding viral or bacterial infection. The immune system mistakenly attacks the body's own tissues, specifically targeting the myelin sheath of the nerves in the brainstem. This demyelination disrupts normal nerve signal transmission. Several pathogens, including Campylobacter jejuni, Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and Mycoplasma pneumoniae, have been associated with the onset of BBE.
Diagnosis
Diagnosis of BBE is primarily clinical, based on the characteristic symptom triad and supported by findings from magnetic resonance imaging (MRI) of the brain, which may show hyperintense lesions in the brainstem. Lumbar puncture (spinal tap) can reveal albuminocytological dissociation (elevated protein with normal white cell count) in the cerebrospinal fluid (CSF), similar to that seen in Guillain-Barré syndrome. Electrophysiological studies may show evidence of demyelination.
Treatment
Treatment of BBE is largely supportive, focusing on managing symptoms and complications. In severe cases, immunotherapies such as intravenous immunoglobulin (IVIG) or plasmapheresis (plasma exchange) may be used to reduce the severity and duration of the illness by removing or diluting the antibodies that are attacking the nervous system.
Prognosis
The prognosis for patients with Bickerstaff Brainstem Encephalitis is generally good, with most patients making a full recovery. However, the recovery period can vary, ranging from a few weeks to several months. Some patients may experience residual symptoms, such as mild ataxia or weakness.
Epidemiology
BBE is a rare condition, with a poorly defined incidence due to its rarity and overlap with other neurological disorders such as Guillain-Barré syndrome. It affects males and females equally and can occur at any age, although it is most commonly reported in adults.
See Also
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD